Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Silverback Therapeutics Inc
(NQ:
SBTX
)
3.250
+0.040 (+1.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
184,365
Open
3.170
Bid (Size)
3.240 (8)
Ask (Size)
3.260 (2)
Prev. Close
3.210
Today's Range
3.120 - 3.250
52wk Range
2.800 - 35.63
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Silverback Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
May 17, 2022
From
Silverback Therapeutics, Inc.
Via
Business Wire
Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
May 12, 2022
From
Silverback Therapeutics, Inc.
Via
Business Wire
Performance
YTD
-51.78%
-51.78%
1 Month
+1.88%
+1.88%
3 Month
-20.73%
-20.73%
6 Month
-55.60%
-55.60%
1 Year
-87.74%
-87.74%
More News
Read More
Stocks That Hit 52-Week Lows On Wednesday
May 11, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2022
April 04, 2022
Via
Benzinga
Silverback Therapeutics Axes Lead Immuno-Oncology Candidates, Lays Off 27% Workforce
April 01, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
April 01, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022
April 01, 2022
Via
Benzinga
Silverback Therapeutics Updates Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results
March 31, 2022
From
Silverback Therapeutics, Inc.
Via
Business Wire
NASDAQ:SBTX Investor Notice: Investigation over Possible Securities Laws Violations by Silverback Therapeutics, Inc.
March 04, 2022
Via
SBWire
Stocks That Hit 52-Week Lows On Thursday
March 31, 2022
Via
Benzinga
Silverback Therapeutics to Present at the 42nd Annual Cowen Healthcare Conference
February 24, 2022
From
Silverback Therapeutics, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
February 08, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 17, 2022
Via
Benzinga
Silverback Therapeutics to Participate in the SVB Leerink 11th Annual Global Healthcare Conference
February 03, 2022
From
Silverback Therapeutics, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
January 14, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
Via
Benzinga
Silverback Therapeutics to Participate in the H.C. Wainwright Bioconnect Conference
January 05, 2022
From
Silverback Therapeutics
Via
Business Wire
Final Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
January 04, 2022
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
SBTX Final Deadline - Bronstein, Gewirtz & Grossman, LLC Reminds Silverback Therapeutics, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 4, 2022
January 04, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Silverback Deadline Alert
January 03, 2022
Via
NewMediaWire
Deadline Tomorrow Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
January 03, 2022
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
SILVERBACK DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Silverback Therapeutics, Inc. and Encourages Investors to Contact the Firm
January 02, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Deadline Tuesday Notice: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
December 31, 2021
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Silverback Shareholder Notice
December 31, 2021
Via
NewMediaWire
Deadline Tuesday Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
December 30, 2021
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.